title: Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock.
abstract: OBJECTIVE
  The mechanisms involved during sepsis-induced immunosuppression are far from being extensively established. The objective of the present study was to investigate whether two characteristics of T cells were altered in this situation: the percentage of circulating gammadelta T lymphocytes and the level of CD3 expression on T lymphocytes.
  
  
  METHODS
  Observational study.
  
  
  METHODS
  Adult intensive care units in a university hospital.
  
  
  METHODS
  Patients with septic shock (n = 21) and healthy individuals (n = 21).
  
  
  METHODS
  None.
  
  
  RESULTS
  In patients, we first observed the decreased percentage of gammadelta T lymphocytes in peripheral blood (1% [0.7-3.1], median [interquartile range]) in comparison with healthy individuals (3.5% [2.1-4.8]). Regarding CD3, we measured a highly significant decrease of its expression on both alphabeta and gammadelta T lymphocytes from patients (p < .005), whereas the CD3 mean fluorescence intensities ratio (gammadelta/alphabeta) was not affected: 2.2 [2.1-2.4] and 2.1 [1.9-2.3] in healthy individuals and septic patients, respectively. The magnitude in the decrease of CD3 expression was thus similar in alphabeta and gammadelta cells, suggesting a common down-regulation mechanism for both T-cell lineages.
  
  
  CONCLUSIONS
  Combined with a reduced percentage of monocytes expressing human leukocyte antigen-DR, a reduced CD3 expression may be involved in the failure of antigen presentation depicted after septic shock, whereas the diminished percentage of circulating gammadelta T cells could be partly responsible for the elevated incidence of secondary infections. These two observations constitute additional pieces of the complex puzzle of sepsis-induced immunosuppression.
authors.affiliation: Immunology Laboratory, Lyon-Sud University Hospital, France.
authors.forename: Fabienne
authors.initials: F
authors.lastname: Venet
authors.forename: Julien
authors.initials: J
authors.lastname: Bohé
authors.forename: Anne-Lise
authors.initials: AL
authors.lastname: Debard
authors.forename: Jacques
authors.initials: J
authors.lastname: Bienvenu
authors.forename: Alain
authors.initials: A
authors.lastname: Lepape
authors.forename: Guillaume
authors.initials: G
authors.lastname: Monneret
mesh_terms: D000368:Aged; D017252:CD3 Complex / Q000097:blood*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000097:blood*; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000097:blood*; D012772:Shock, Septic / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D017252:CD3 Complex; D016693:Receptors, Antigen, T-Cell, alpha-beta; D016692:Receptors, Antigen, T-Cell, gamma-delta